NIBSC标准品产品代理

金山科研平台代理微信：jinshanbio英国国家生物制品检定所是WHO的一个标准品供应中心实验室，它的核心工作是制备、保存和分发WHO用于检测生物制品质量的标准品。NIBSC制备的流感毒株和检测抗原、抗血清标准品，保障了各厂家顺利的研究和生产。

　英国国家生物制品检定所（National Institute for Biological Standards and Control，NIBSC）

　　英国国家生物制品检定所是WHO的一个标准品供应中心实验室，它的核心工作是制备、保存和分发WHO用于检测生物制品质量的标准品。NIBSC制备的流感毒株和检测抗原、抗血清标准品，保障了各厂家顺利的研究和生产。

　　NIBSC提供对投入英国市场的生物药品的独立测试，尤其是用于英国儿童免疫计划的疫苗；它同时也是欧盟控制药品进入欧盟市场的*药品控制实验室（OMCL）。 如果出现不能满足药品存放要求或患者出现不良反应等问题，NIBSC 也可对已投入欧盟市场的产品进行检验。

　　NIBSC认为对 NIBSC工作的核心职能制定并维护一项既均衡而又主次分明的计划至关重要。控制和评估生物药品。开发和提供关键的生物学标准和其它参考资料。开展针对任务的研究和开发工作。

Streptokinase 00/464Interferon Beta （Human, rDNA; CHO cell-derived; Glycosylated） 00/572Interferon Beta Ser 17 Human, recDNA, E-coli-derived, non-glycosylated 00/574Interferon Beta, Human, Fibroblast Cell-Derived, Glycosylated 00/576Interleukin-17 Human rec DNA 01/420Vascular Endothelial Growth Factor, Human rDNA derived 01/424Botulinum Antitoxin Equine Type D 01/510Anti-D Immunoglobulin 01/572Thrombin, human, 2nd International Standard 01/580Low Molecular Weight Heparin, 2nd International Standard 01/608Blood Coagulation Factor VIII Concentrate, Human 02/122Prekallikrein Activator （PKA）, Human 02/168Blood Coagulation Factor XIII, Plasma, Human 1st IS 02/206IVIG negative control for use with IVIG + anti-D 02/226IVIG + anti-D for use with negative control IVIG 02/228Vascular Endothelial Growth Factor 02/286Blood Coagulation Factor V, Plasma（1st I.S.） 03/116Thrombopoietin, human rDNA derived 03/124Keratinocyte growth factor （KGF, FGF-7）（24-163） 03/148Keratinocyte Growth Factor （KGF,FGF-7） 03/150Thyroid Stimulating Hormone, recombinant 03/192Interleukin - 18 （Human rDNA derived） 03/200IVIG + Anti-D for use with negative control IVIG 04/132IVIG Negative Control for use with IVIG & Anti-D 04/140TNF-related Apoptosis-Inducing Ligand （trail）, Human, rDNA-derived 04/166Parathyroid hormone 1-34 Recombinant, Human 04/200Protein C Concentrate, Human 04/252Low Molecular Weight Heparin for Molecular Weight Calibration （2nd International Standard）. 05/112Alpha-1-Antitrypsin, plasma derived 05/162IVIG, Anti-D and Negative Control Panel 05/242Antithrombin Concentrate, Human 06/166FEIBA Concentrate 1st NIBSC Working Reference Standard 06/172Blood Coagulation Factor IX Concentrate, Human, 4th International Standard” 07/182Blood Coagulation Factor VIIa, Concentrate, Human, 2nd International Standard” 07/228Anti-D for assuring operator and test performance 07/304Anti-A and Anti-B in IVIG Positive Control 07/306Anti-A and Anti-B in IVIG Negative Control 07/308Anti-A and anti-B in IVIG: Limit reference preparation 07/310Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma （6th I.S.） 07/316Blood Coagulation Factors II, IX,and X Concentrate, 6th British Working Standard. 07/326Unfractionated Heparin （6th I.S.） 07/328Blood Coagulation Factor VIII Concentrate （8th I.S.） 07/350Chorionic Gonadotrophin, （5th International Standard） 07/364Streptodornase （2nd International Standard） 08/230C1- Inhibitor, Concentrate （1st International Standard） 08/256Anti-A and Anti-B in IVIG: Positive and Negative control panel. （2 ampoules of 07/306 and 2 ampoules of 07/308） 08/270Follicle-Stimulating Hormone, human, recombinant, for bioassay （2nd International Standard） 08/282Granulocyte Colony Stimulating Factor （Human, rDNA Derived）（2nd International Standard） 09/136VWF Factor Concentrate （2nd International Standard） 09/182Corticotrophin （ACTH）, Porcine 59/016Serum Gonadotrophin, Equine 62/001Lysine Vasopressin, Porcine 62/014Renin, Porcine 65/119Gastrin II, Porcine 66/138Interferon, Chick 67/018Renin, Human 68/356Glucagon, Porcine 69/194Angiotensin II 70/302Angiotensin I 71/328Corticotrophin （ACTH）, Human 74/555Ancrod 74/581Blood Coagulation Factor Xa, Bovine 75/595Oxytocin 76/575Lysine Vasopressin 77/512Secretin 77/643Kininogenase, Porcine 78/543Luteinizing Hormone, Pituitary, alpha subunit 78/554Luteinizing Hormone, Pituitary, beta subunit 78/556Prekallikrein Activator （PKA）, Human 79/572Growth Hormone, Human, Pituitary 80/505Luteinizing Hormone, Human, Pituitary 80/552Tetracosactide 80/590Parathyroid Hormone, Human-Type, Synthetic （1-34） fragment 82/508Parathyroid Hormone, Bovine-Type, Synthetic （1-34） fragment 82/512Interferon Gamma （Human, Leukocyte derived） 82/587Parathyroid Hormone, Bovine 82/632Insulin, Human 83/500Beta Thromboglobulin, Purified Human 83/501Plaet Factor 4 Human, Purified 83/505Insulin, Bovine 83/511Interferon alpha-1D, （Human rDNA derived） 83/514Insulin, Porcine 83/515Prolactin, Human 83/573Follicle Stimulating Hormone, Pituitary 83/575Prolactin, Human 84/500Calcitonin, ASU 1-7 Eel Calcitonin Analogue （Elcatonin） 84/614C-Reactive Protein, Human 85/506Atrial Natriuretic Factor, Human 85/669Interleukin-2 （Human, Jurkat derived） 86/504Angiotensin I Human Type Synthetic 86/536Angiotensin II 86/538Interleukin-1 Beta （Human, rDNA derived） 86/552Interleukin-2 （Human, rDNA derived） 86/564Interleukin-1 alpha （Human rDNA derived） 86/632Interleukin-1 alpha （Human, rDNA derived） 86/678Interleukin-1 beta （Human, rDNA derived） 86/680Inhibin, Porcine 86/690Interferon Gamma （Human, rDNA derived） 87/586Urokinase, High Molecular Weight 87/594Tumour Necrosis Factor beta （Human, rDNA derived） 87/640Tumour Necrosis Factor alpha （Mouse, rDNA derived） 88/532Calcitonin, Eel 88/556Erythropoietin, Human recombinant 88/574Granulocyte Macrophage Colony Stimulating Factor （Human, rDNA derived） 88/646Interleukin-4 （Human, rDNA derived） 88/656Tumour Necrosis Factor alpha （Human Natural） 88/786Macrophage Colony Stimulating Factor （CSF-1） （Human rDNA derived） 89/512Transforming Growth Factor beta-1 （Human, rDNA derived） 89/514Transforming Growth Factor beta-1 （Bovine） 89/516Transforming Growth Factor beta-2 （Bovine） 89/518Interleukin-8 （Human, rDNA derived） 89/520Renin, Human, rec DNA 89/544Interleukin-6 （Human, rDNA derived） 89/548Calcitonin, Human 89/620Interleukin-7 （Human, rDNA derived） 90/530Interleukin-5 （Human, rDNA derived） 90/586Transforming Growth Factor beta-2, Human, rec DNA 90/696Basic Fibroblast Growth Factor （Human, rDNA derived） 90/712Interleukin-3 （Human, rDNA derived） 91/510Epidermal Growth Factor （Human, rDNA derived） 91/530Epidermal Growth Factor （1-52） （Human, rDNA derived） 91/550Insulin-like growth Factor 1 91/554Inhibin A, Human, recombinant 91/624Activin A, Human, Recombinant 91/626Interleukin-4 （Mouse, rDNA derived） 91/656Granulocyte Macrophage Colony Stimulating Factor （Mouse rDNA derived） 91/658Interleukin-3 （Mouse, rDNA derived） 91/662Interleukin-9 （Human,rDNA derived） 91/678Stem Cell Factor （Human rDNA derived） 91/682Follicle Stimulating Hormone, Human, recombinant 92/510Follicle Stimulating Hormone, urofollitropin Human Urinary 92/512Macrophage Inflammatory Protein-1 alpha （Human, rDNA derived） 92/518Rantes （Human, rDNA derived） 92/520Interleukin-1 Receptor Antagonist （IL-1ra） （Human, rDNA derived） 92/644Plasminogen Activator Inhibitor-1 （PAI-1）, plasma Human 92/654Serum amyloid A protein 92/680Interleukin-11 （Human, rDNA derived） 92/788Monocyte Chemoattractant Protein-1 （Human,rDNA derived） 92/794Soluble Tumor Necrosis Receptor factor Type II （Human, rDNA derived） 93/524Batroxobin 93/526Nerve Growth Factor （Human, rDNA derived） 93/556Leukaemia Inhibitory Factor （Human, rDNA derived） 93/562Oncostatin M （Human, rDNA derived） 93/564Interleukin-2 （Mouse, rDNA derived） 93/566Bone morphogenetic Protein-2 （Human, rDNA derived） 93/574Interleukin-1 beta （Mouse, rDNA derived） 93/668Interleukin-1 alpha （Mouse, rDNA derived） 93/672Interleukin-10 （Human rDNA derived） 93/722Interleukin-6 （Mouse, rDNA derived） 93/730Interleukin-7 （Mouse, rDNA derived） 93/740Endotoxin 94/580Interleukin-13 （Human, rDNA derived） 94/622Ciliary Neurotrophic Factor （Human, rDNA derived） 94/684Straphylokinase, rec （STAR） 94/718Plaet-derived Growth Factor-BB （Human, rDNA derived） 94/728Tissue Plasminogen Activator （tPA） Antigen in Plasma 94/730Interferon Omega （Human, rDNA derived） 94/754Interferon alpha （Human, leukocyte derived） 94/784Interferon alpha Concensus Sequence （Human rDNA derived） 94/786Interleukin-12 （Human, rDNA derived） 95/544Interleukin-15 （Human, rDNA derived） 95/554Single Chain Urinary-Type Plasminogen Activator （SCuPA）, （Non-Glyc） 95/564Interferon alpha-2b （Human, rDNA derived） 95/566Interferon Alpha n1 （Human lymphoblastoid cell derived） 95/568Interferon alpha-1/8 （Human, rDNA derived） 95/572Interferon Alpha n3 （Human, leukocyte derived） 95/574Interferon alpha-2c （Human, rDNA derived） 95/580Interferon alpha-2a （Human, rDNA derived） 95/650Single Chain Urinary-Type Plasminogen Activator （SCuPA）, （Glyc） 95/668Soluble Tumour Necrosis Factor Receptor Type 1, （Human, rDNA derived） 96/528FMS-like tyrosine kinase 3 ligand （Human, rDNA derived） 96/532Brain-derived Neurotrophic Factor （Human, rDNA derived） 96/534Insulin-like growth Factor-II （Human rDNA derived） 96/538Hepatocyte Growth Factor/Scatter Factor （precursor）, （Human rDNA derived） 96/556Hepatocyte Growth Factor/Scatter Factor （Human, rDNA derived） 96/564Luteinizing Hormone, Human, recombinant 96/602Inhibin B, Human 96/784Plasmin, Human 97/536Anti-Granulocyte Macrophage Colony Stimulating Factor Serum 97/538Blood Coagulation Factors IXa Concentrate, Human, recombinant（1st I.S.） 97/562Blood Coagulation Factor VII Concentrate（1st I.S.） 97/592Leptin, Human, Recombinant 97/594Interleukin-2 Soluble Receptor （human, rDNA derived） 97/600Leptin, Mouse, Recombinant 97/626Somatropin 98/574Calcitonin, Salmon 98/586Blood Coagulation Factors II and X Concentrate（3rd I.S.） 98/590Transforming Growth Factor beta-3 （Human, rDNA derived） 98/608Fibrinogen, Plasma, Human, 2nd IS 98/612Fibrinogen Concentrate, Human, 1st International Standard 98/614Follicle Stimulating Hormone and Luteinizing Hormone, Human Urinary 98/704Tissue Plasminogen Activator, Human, Recombinant 98/714Neurotrophin 3 98/718Biotinylated Brad-5 （Bio-Brad-5） 99/698Anti-D Immunoglobulin Control 99/728Biotinylated Brad-5 99/774Thromboplastin,rabbit,plain（pack of 5 ampoules） with diluent （pack of 5 04/210） RBT/05Thromboplastin, Human Recombinant, Plain （4th I.S.） （Panel of 5 ampoules for use with 5 diluent 08/146）. RTF/09DiagnosticsHepatitis A Virus RNA NAT Assays 00/560Hepatitis B Surface Antigen （HBsAg） subtype adw2, genotype A 00/588Hepatitis A Virus RNA Working Reagent for NAT assays 01/488Anti-Toxoplasma IgG, Human 01/600Anti-Parvovirus B19, plasma, human 01/602HIV （antibody）, 1st International Reference Panel 02/210Insulin-like growth Factor I 02/254HCV RNA Working Reagent for Nucleic Acid Amplification Techniques 02/264-003Protein C Plasma 02/342HTLV-1 （antibody） Monitor Sample 03/104-009Anti-HPA-1a standard 03/152Anti-B minimum potency reference preparation 03/164Vitamin B12, Serum Folate 03/178Anti-A minimum potency reference preparation 03/188Anti-HPA-3a（minimum potency） 03/190Protein S, Plasma, Human 03/228Hepatitis B Surface Antigen subtype adw2, genotype A Reference Panel 03/262QCRHSV2QC1-Anti-HSV2 Quality Control Serum: Sample1 03/B346-06Blood Coagulation Factor XI Plasma, Human（1st I.S.） 04/102Plasmodium falciparum DNA for NAT Assays 04/176Factor V Leiden, Human gDNA, 1st International Genetic Reference Panel 2004 04/224Anti-HPA-1a minimum potency reagent 05/106Anti-syphilis plasma IgG （human） 05/122Prothrombin Mutation G20210A, Human gDNA, 1st International Genetic Reference Panel 2005 05/130Anti-syphilis plasma IgG and IgM （human） 05/132HIV-1 RNA Working Reagent 3 for NAT Assays 05/158-002HLA-A Genotyping Reference Panel. 05/208-001QCRTOXOQC1-Anti-Toxoplasma Quality Control Serum: Sample 1 05/B433-06Hepatitis C Virus （HCV） RNA 06/100Anti Hepatitis C Virus 06/188-006Anti-HCV （1 in 8 dilution） 06/190-008HPV 16 DNA 06/202HPV 18 DNA 06/206QCRHIV1QC5-Anti-HIV1: Quality Control Serum: Sample5 06/B461-04QCRMALQC1-Anti-Malaria Quality Control Serum: Sample1 06/B475-06Anti-HBs immunoglobulin 07/164Recombinant soluble transferrin receptor （rsTfR）（1st WHO Reference Reagent） 07/202Positive control for FCXM 07/214RhD/SRY Plasma DNA sensitivity standard 07/222Hepatitis B Surface Antigen Monitor Sample 07/286-006Hepatitis B Surface Antigen 0.2IU/ml 07/288-004Norovirus GII for Nucleic Acid Amplification Techniques 07/294-001Influenza Virus （A/Christchurch/1/2003, H1N1） for Nucleic Acid Amplification Techniques 07/296-001Influenza Virus （A/Wyoming/3/2003, H3N2） for Nucleic Acid Amplification Techniques 07/298-001Influenza Virus （B/Jiangsu/10/2003） for Nucleic Acid Amplification Techniques 07/300-001QCRHBclgMQC1-IgM Anti-HBc Quality Control Serum: Sample1 07/B498-08QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample1 07/B506-09QCRTHBcQC1-Total Anti-HBc Quality Control Serum: Sample 1 07/B506-11QCRTHBcQC2-Total Anti-HBc Quality Control Serum: Sample2 07/B512-06QCRHBsQC1-Anti HBs Quality Control Serum: Sample1 07/B515-06QCRHIV1P24QC1-HIV1 p24 Antigen: Quality Control Serum: Sample1 07/B519-12Human Adenovirus serotype 2 for Nucleic Acid Amplification Techniques 08/114-001Parainfluenza Virus serotype 3 for Nucleic Acid Amplification Techniques 08/118-001Human Respiratory syncytial virus A2 for Nucleic Acid Amplification Techniques 08/120-001HIV-2 RNA（1st International Standard） 08/150Fragile X Syndrome gDNA Genetic Reference Panel 08/158Haemophilia A, Intron-22 inversion, gDNA, Genetic Reference Panel 08/160Human Coxsackie B4 for Nucleic Acid Amplification Techniques 08/174-001Parainfluenza Virus serotype 1 for Nucleic Acid Amplification Techniques 08/176-001Parainfluenza Virus serotype 2 for Nucleic Acid Amplification Techniques 08/178-001Parainfluenza virus serotype 4 for Nucleic Acid Amplification Techniques 08/180-001Thyroid Stimulating Antibody （2nd I.S.） 08/204Human Herpes Simplex virus type 1 for Nucleic Acid Amplification Techniques 08/224-001Human Herpes Simplex virus type 2 for Nucleic Acid Amplification Techniques 08/226-001Antithrombin, Plasma （3rd International Standard） 08/258C1 Inhibitor （Plasma）（1st International Standard） 08/262HCV RNA Genotype Panel for Nucleic acid amplification techniques 08/264Sex Hormone Binding Globulin. （2nd International Standard） 08/266Varicella Zoster Virus （Type B） Working Reagent for Nucleic Acid Amplification Testing （NAT） 08/310-001Human Cytomegalovirus for Nucleic Acid Amplification Techniques 08/314-002Epstein-Barr Virus for Nucleic Acid Amplification Techniques 08/316-001Human Norovirus GI Working Reagent for Nucleic Acid Amplification Testing 08/318-001Human Metapneumovirus Working Reagent for Nucleic Acid Amplification Testing 08/320-001Human Parechovirus Working Reagent for Nucleic Acid Amplification Testing 08/322-001Human Rhinovirus Genogroup A Working Reagent for Nucleic Acid Amplification Testing 08/324-001HIV-1RNA Genotype Panel 08/358QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample1 08/B523-03QCRVZVQC1-AntiVZV: Quality Control Serum: Sample1 08/B531-06QCRHIV2QC3-Anti HIV2: Quality Control Serum: Sample3 08/B534-03QCRHIV1P24QC2-HIV1 p24 Antigen: Quality Control Serum: Sample2 08/B536-05QCRHIV1QC1-Anti-HIV1:Quality Control Serum: Sample1 08/B538-04QCRNEGQC1-Negative Quality Control Serum: Sample1 08/B539-06QCRHCVQC1-Anti-HCV Quality Control Serum: Sample1 08/B542-06QCRHIV2QC2-Anti HIV2:Quality Control Serum: Sample2 08/B544-06QCRCMVQC1-Anti CMV: Quality Control Serum: Sample1 08/B549-06QCRHBeQC1-Anti-HBe Quality Control Serum: sample1 08/B554-04Parvovirus B19 DNA Nucleic Acid Amplification Technology（NAT） based assays Genotype Panel（1st International Standard） 09/110Negative Control for FCXM 09/112Human Coronavirus 229E Working Reagent for Nucleic Acid Amplification Testing 09/132-001Genetic Reference Panel, for the quantitation of BCR-ABL translocation by RQ-PCR （1st I.S.） 09/138Prader Willi & Angelman Syndromes, Human gDNA,（1st International Genetic Reference Panel） 09/140Human Cytomegalovirus （HCMV） for Nucleic Acid Amplification Techniques （1st International Standard） 09/162Blood coagulation Factors II, VII, IX, X Plasma （4th International Standard） 09/172Neisseria meningitidis for Nucleic Acid Amplification Testing （NAT） 09/320-001QCRSYPHQC2-Anti-Syphilis Quality Control Serum: sample2 09/B559-06QCRHIV1QC3- Anti-HIV1:Quality Control Serum: Sample3 09/B562-01QCRHBsGQC1-Anti HBsAg Quality Control Serum: Sample1 09/B564-02QCRHBsGQC2-Anti HBsAg Quality Control Serum: Sample2 09/B566-01QCRHIV1QC2- Anti-HIV 1: Quality Control Serum: Sample 2 09/B571-02QCRHAVIgMQC2-Anti-HAV Quality Control Serum: Sample2 09/B572-05QCRRUBQC1-Anti-Rubella Quality Control Serum: Sample1 09/B577-01QCRTHAVQC1-Total Anti-HAV Quality Control Serum: Sample1 09/B584-01QCRSYPHQC1-Anti-Syphilis Quality Control Serum: Sample 1 09/B585-03QCRHBsQC1-Anti HBs Quality Control Serum: Sample1 09/B587-02HBV DNA PCR Reference 10/194-001Rheumatoid Arthritis Serum 64/002Anti-Thyroglobulin Serum, Human 65/093Long-acting Thyroid Stimulator, Human 65/122Anti-Nuclear Factor Serum （Homogenous） Human 66/233Insulin, Human 66/304Anti-thyroid Microsome Serum, Human 66/387Immunoglobulin D （IgD） Serum, Human 67/037Immunoglobulins G, A, M Serum Human 67/086Immunoglobulins G, A & M Serum Human 67/099Primary Biliary Cirrhosis Serum, Human 67/183Erythropoietin, Human, Urinary 67/343Anti-Nucleolar Factor Plasma, Human 68/340Autoimmune Antibody to Human Spermatazoa 69/065Anti-D （Rho） Antibodies, Human 73/515Placental Lactogen, Human 73/545Carcinoembryonic Antigen （CEA）, Human 73/601Serum Proteins （Other than Immunoglobulins） Human 74/520Corticotrophin （ACTH）, Porcine 74/586Serum Immunoglobulin E （IgE） Human 75/502Cocksfoot Pollen Extract 75/506Chorionic Gonadotrophin, Human, for Radioiodination 75/533Chorionic Gonadotrophin beta, Human, for Radioiodination 75/535Parathyroid Hormone, Human 75/549Chorionic Gonadotrophin beta Subunit, Human 75/551Chorionic Gonadotrophin alpha subunit, Human 75/569Chorionic Gonadotrophin alpha Subunit, Human, for Radioiodination 76/508Mannan （C. Albians） Purified 76/515Anti-Birch Pollen Serum, Human 76/525Anti-Cocksfoot Serum, Human 77/503Anti-D Pteronyssinus Serum, Human 77/584Mannan （C. Albicans） Purified 77/600Twelve Grass Pollen Extract 77/616Acarus Siro Extract 77/662Glycyphagus destructor Extract 77/664Tyrophagus Putrescentiae Extract 78/517Anti-Aspergillus fumigatus Serum, Human 78/545Aspergillus Fumigatus Extract 78/575Tyrophagus Longior Extract 78/582Bee Venom 78/628Parathyroid Hormone, Human 79/500Anti-Cat Fur Serum, Human 79/530Thyroid Stimulating Hormone, Human 81/565Dermatophagoides Pteronyssinus Extract 82/518Timothy Pollen Extract 82/520Human Serum Vitamin B12, Pernicous anaemia 82/652C- Peptide of Human Insulin 84/510Proinsulin, Bovine 84/514Birch Pollen Extract 84/522Proinsulin, Porcine 84/528Short Ragweed Pollen Extract 84/581Proinsulin, Human 84/611Anti-c Serum, Human 84/628Dog （Canis Familiaris） Hair Dander Extract 84/685Thyroid Stimulating Hormone beta subunit 85/522Anti-Rye Grass Serum, Human 85/551Haemoglobin F Lysate, Raised 85/616Anti-Ferritin Monoclonal Antibody （1） 87/654Anti-Ferritin Monoclonal Antibody （2） 87/662Thyroxine-binding globulin 88/638Haemoglobin A2 Lysate, Raised 89/666HIV-1 P24 Antigen 90/636Anti-Varicella-Zoster Antibody 90/690Anti-D for use with papain preparation 92/658 91/562Papain preparation for use with Anti-D preparation 91/562 92/658Insulin-like growth Factor Binding Protein-3 93/560Ferritin, Human, recombinant 94/572Follicle Stimulating Hormone/Luteinizing Hormone, Human Pituitary 94/632Thyroid Stimulating Hormone, Human recombinant 94/674Anti-HBc （Anti-hepatitis B core antigen） 95/522Folate, Whole Blood 95/528Anti-hepatitis E Serum, Human 95/584Parathyroid Hormone 1-84, human, recombinant（1st International Standard） 95/646Lupus Anticoagulant Negative Control 96/522Anti-Human Globulin 96/666Prostate Specific Antigen （free） 96/668Prostate Specific Antigen （90:10） 96/670Islet Cell Antibodies 97/550Anti-Hepatitis A Immunoglobulin, Human （W1041） 97/646HIV-1 RNA, 2nd International Standard 97/650Prolactin, Human, recombinant 97/714Hepatitis B Virus DNA for nucleic acid amplification techniques 97/750Prolactin Human, recombinant, glycosylated 98/580Prolactin, Human, recombinant, non-glycosylated 98/582Haemiglobincyanide 98/708HIV-1 RNA Working Reagent 1 （PWS-1） for NAT Assays 99/634-005HIV-1 RNA Working Reagent 2 for NAT assays 99/636-005Chorionic Gonadotrophin, nicked, human 99/642Chorionic Gonadotrophin, beta subunit, human 99/650Anti-HPA-5b （Minimum Potency） 99/666HIV-2 （antibody） Monitor Sample 99/674-010Chorionic Gonadatrophin, intact, Human 99/688Chorionic Gonadotrophin, nicked beta subunit, Human 99/692Chorionic Gonadatrophin, beta core fragment, Human 99/708HIV-1 （antibody） （1 in 5 dilution） British Working Standard 99/710-012Chorionic Gonadotrophin, alpha subunit, Human （purified） 99/720Multiplex Working Reagent （HCV, HBV, HAV, HIV, B19） 99/732Parvovirus B19 DNA Working reagent 99/736HIV-1 （antibody） British Working Standard） 99/750-013B19 DNA NAT assays.2nd I.S. 99/802Anti-D Minimum Potency Standard for blood grouping reagents 99/836Alpha-Foetoprotein AFPBeta-2 Microglobulin B2MAnti-Canine Distemper Serum CDSCholera Antitoxin, Goat CHANAnti-Canine Hepatitis Serum CHSAnti-Dysentery （shiga） serum, Equine DYAnti-Echinococcus Serum, Human ECHSAnti-Mycoplasma gallisepticum Serum MGDSAnti-Newcastle Disease Serum NDSAnti-Q Fever Serum, Bovine QFAnti-rabies Immunoglobulin, Human RAISwine Erysipelas Serum （anti-N） SESAnti-Swine Fever Serum SFSAnti-Salmonella Pullorum Serum （Std. Form S） SPDS-S2Anti-Salmonella Pullorum Serum （Variant Form V） SPDS-VAnti-tick borne encephalitis serum TILIAnti-tick borne encephalitis serum TISAAnti-C complete blood typing serum,human W1004Anti-E complete blood typing serum, human W1005Anti-c Incomplete blood typing serum, human W1007Anti-Varicella zoster immunoglobulin W1044Anti smooth muscle（anti actin） autoantibody. W1062Anti nuclear ribonucleoprotein（nRNP） autoantibody W1063Anti-Nuclear factor serum,homogenous（66/233） W1064Rheumatoid Arthritis serum. W1066VaccinesMAPREC assay of poliovirus type 1 （Sabin）.100% 480-A, 525-C DNA（1st International Reference Preparation） 00/410MAPREC assay of poliovirus type 1 （Sabin） Low Mutant Virus Reference（1st International Reference Preparation） 00/416MAPREC assay of poliovirus type 1 （Sabin） （1st International Standard） 00/418MAPREC assay of poliovirus type 1 （Sabin） High Mutant Virus Reference（1st International Reference Preparation） 00/422Influenza anti A/Singapore/1/57 Serum （sheep） H2 00/440Influenza anti B/Yamanashi/166/98 Serum （sheep） 00/442Diphtheria Antitoxin Human Serum 00/496Botulinum Antitoxin Human 00/500Influenza Virus infectious B/Sichuan/379/99 00/530Influenza Virus infectious B/Johannesburg/5/99 00/532Influenza anti A/Chick/Scotland/59 （H5N1） Serum （sheep） 00/542Influenza Virus infectious B/Victoria/504/00 00/544Influenza Antigen B/Johannesburg/5/99 00/546Influenza Antigen A/duck/Singapore/97 （H5N3） 00/552Influenza anti B/Johannesburg/5/99/ Serum （sheep） 00/556Influenza Virus infectious B/Guangdong/120/00 00/614Anti-Meningococcal immunotype L3,7,9 mAb 01/412Meningococcal group Y polysaccharide 01/426Meningococcal group W135 polysaccharide 01/428Influenza anti B/Guangdong/120/2000 Serum （sheep） 01/450Influenza anti A/Panama/2007/99 Serum （sheep） 01/452Botulinum Antitoxin Equine Type F 01/506Botulinum Antitoxin Equine Type C 01/508Botulinum Antitoxin Equine Type G 01/512Anti-Meningococcal Serosubtype P1.7 mAb 01/514Oral Poliovaccine Sabin Reference Preparation Type 1[LS-c, 2ab strain] 01/528Oral Poliovaccine Sabin Reference Preparation Type 2 01/530Oral Poliovaccine Sabin Reference Preparation Type 3 01/532Anti-Meningococcal Serosubtype P1.16 mAb 01/538Influenza Antigen B/Guangdong/120/2000 01/546Influenza Virus infectious B/Hawaii/10/01 01/612Influenza Antigen A/New Caledonia/20/99 01/614Influenza anti A/Panama/2007/99 Serum （sheep） 02/102Anti-Meningococcal Serosubtype P1.15 mAb 02/144Anti-Meningococcal Serosubtype P1.4 mAb 02/148Diphtheria Toxoid for use in Flocculation Test. 02/176Anti-Meningococcal Serosubtype P1.2 mAb 02/178Anti-Meningococcal Serotype P2.2a mAb 02/180Anti-Japanese Encephalitis Virus Plasma, Human 02/182Anti-Japanese Encephalitis （Anti-JE） Virus Control Plasma, Human 02/184Anti-Dengue Virus Types 1+2+3+4, Human 02/186Haemophilus influenzae b PRP 02/208Tetanus Toxoid Not Adsorbed 02/232Influenza Virus infectious B/Brisbane/32/2002 02/262Influenza anti A/chick/Italy/13474/99 （H7N1） Serum （sheep） 02/294Polio Virus Sabin Types 1, 2 and 3 02/306Anti-Meningococcal Serotype P3.4 mAb 02/308Anti-Meningococcal Serotype P3.15 mAb 02/310Botulinum Antitoxin Equine Type E 02/318Anti-Meningococcal Serosubtype P1.3 mAb 02/320Influenza Antigen A/New Caledonia/20/99 02/336Influenza anti A/Panama/2007/99 Serum （sheep） 02/338Influenza anti B/Shangdong/9/97 Serum （sheep） 03/110Anti-Meningococcal Serosutype P1.1 mAb 03/114Anti-Meningococcal Serosubtype P1.14 mAb 03/142Anti-Meningococcal Serotype P3.21 mAb 03/182Influenza Virus infectious A/Kumamoto/102/02 03/198Anti-Meningiococcal Serosubtype P1.6 mAb 03/210Influenza anti A/Wyoming/03/03 Serum 03/212Influenza Antigen A/Wyoming/03/03 03/220Anti-Meningococcal Serosubtype P1.10 mAb 03/224Anti-Meningococcal Serosubtype P1.5 mAb 03/226Anti-Meningococcal Serosubtype P1.13 mAb 03/236Influenza anti A/Puerto Rico/8/34 （H1N1） HA Serum 03/242Influenza anti A/chick/Germany/N/49 （H10N7） HA Serum （sheep） 03/244Influenza Antigen A/New Caledonia/20/99 （IVR-116） 03/258Anti-Meningococcal Serosubtype P1.12 mAb 04/122Tetanus Toxoid For Flocculation Test 04/150Influenza Virus infectious NYMC X-147 04/160Influenza Virus infectious A/Wellington/1/2004 04/170Influenza Virus infectious IVR-139 04/172Anti-Meningococcal Serotype P3.1 mAb 04/198Influenza Antigen B/ Jiangsu/10/2003 04/202Influenza anti A/Vietnam/1194/04 （NIBRG-14） HA Serum （sheep SH440&SH442） 04/214Influenza anti B/ Neuraminidase Serum 04/228Influenza anti N1 Neuraminidase Serum 04/230Influenza anti B/Jiangsu/10/2003 HA Serum （sheep） 04/242Anti-Meningococcal Serogroup W-135 mAb 04/246Anti-Meningococcal Serosubtype P1.19 mAb 04/248Influenza Virus infectious A/New York/55/2004 04/254Influenza anti N2 Neuraminidase Serum（prepared from A/Wyoming/3/2003） 04/258Influenza anti A/New Caledonia/20/99 HA Serum （sheep） 04/260Influenza anti A/New York/55/2004 HA Serum （sheep） 04/262Influenza Antigen A/New York/55/2004 （H3N2） （NYMC X-157） 04/264Influenza Virus infectious NYMC BX-7 05/102Influenza Virus infectious A/California/7/2004 05/110Anti-human papillomavirus type 16 serum （1st International Standard） 05/134Influenza Virus infectious B/Shanghai/361/2002 05/138Anti Meningococcal Serosubtype P1.9 Monoclonal Antibody 05/190Anti Meningococcal Serotype P2.2b Monoclonal Antibody 05/192Influenza Virus infectious A/Hiroshima/52/2005 05/232Influenza Antigen A/Wisconsin/67/2005 - Like 05/234Influenza anti A/Wisconsin/67/2005 Serum （sheep） 05/236Influenza Virus infectious NYMC X-161 05/244Anti Dengue, WHO Reference Panel 05/248Influenza anti B Neuraminidase Serum （Sheep SH463） 05/252Influenza Antigen A/Wisconsin/67/2005 （H3N2） （NYMCX-161） 06/106Influenza Virus infectious IVR-116 06/108Influenza Virus Infectious A/PR/8/34 06/114Monoclonal Antibody for Serotyping Bordela pertussis Fimbrial Antigen 2 （1st International Standard） 06/124Monoclonal Antibody for Serotyping Bordela pertussis Fimbrial Antigen 3 （1st International Standard） 06/128Pertussis Antiserum （human）1st IS - WHO international Standard. 06/140Pertussis Antiserum （Human） 1st WHO Reference Reagent 06/142Influenza Virus infectious 1 VR-142 06/164Influenza Antigen A/New Caledonia/20/99 06/170Influenza Virus infectious A/Wisconsin/67/2005 06/184Influenza anti A/turkey/Turkey/1/05 （NIBRG-23） HA serum（sheepSH465 & SH466） 06/192Medium Titre Meningococcal OMV Ref. serum 06/210Influenza Virus infectious A/Solomon Islands/3/2006 07/132 06/236Influenza Virus infectious NYMC-X161 B 06/242Influenza Antigen A/Solomon Islands/3/2006 （IVR-145）（H1N1） 07/102Influenza anti A/Solomon Islands/3/2006 （H1N1） （IVR-145） HA Serum （sheep 467,468,469,470） 07/104Influenza Antigen A/turkey/Turkey/1/2005 （H5N1） NIBRG-23 07/112Influenza Virus infectious B/Malaysia/2506/2004 07/132Influenza Virus infectious IVR-145, 07/144Influenza anti A/HongKong/1073/99 like HA Serum （sheep） 07/146Influenza anti A/Vietnam/1194/04 （H5N1） HA Serum 07/148Human Plasma Anti-Influenza H5N1 07/150Rabies vaccine 07/162Influenza anti B/Malaysia/2506/2004-HA Serum （sheep） 07/184Diphtheria Toxoid （Adsorbed） （4th International Standard） 07/216Influenza Virus Infectious A/New Caledonia/20/99 07/226Influenza Virus Infectious IVR-147 07/246Influenza Virus infectious NIBRG-14 07/252Influenza Virus Infectious B/Brisbane/3/2007 07/268BCG Vaccine of Danish 1331 sub-strain （1st WHO Reference Reagent） 07/270BCG Vaccine of Tokyo 172 sub-strain（1st WHO Reference Reagent） 07/272BCG Vaccine of Russian BCG-I sub-strain（1st WHO Reference Reagent） 07/274Influenza anti A/mallard/Netherlands/12/2000 （H7） HA serum （NIBRG-60） （sheep SH474 AND SH475） 07/278Influenza Antigen A/Anhui/1/05 （H5N1） IBCDC-RG-6 07/290Meningococcal Group C Polysaccharide 07/318Influenza Antigen A/mallard/Netherlands/12/00 （H7N3） NIBRG-60 07/336Influenza anti A/Anhui/1/05 （H5） HA serum （IBCDC-RG6） （Sheep SH477） 07/338Influenza Virus infectious NYMC X-171B 07/348Influenza Virus infectious A/Uruguay/716/2007 07/354Influenza Anti-B/Florida/4/2006 HA serum （sheep 478, 479） 07/356Influenza Virus infectious NIB-50 07/358Influenza Virus infectious IVR-149 07/362Influenza Antigen A/Brisbane/59/2007 （IVR-148） （H1N1） 08/100Influenza Virus Infectious NIBRG-91 08/108Influenza Virus Infectious NIBRG-88 08/110Influenza anti A/turkey/Turkey/1/05（N1） NA Serum （NIBRG-74） （Sheep SH485） 08/126Influenza Virus Infectious B/Florida/4/2006 08/138Influenza Antigen B/Florida/4/2006 08/140Influenza anti A/Anhui/1/05 （H5） HA serum （IBCDC-RG6） （sheep SH477） 08/142Influenza Virus Infectious NIBRG-12 08/154Influenza Virus Infectious NIBRG-23 30060 VE3 08/156Influenza Antigen B/Malaysia/2506/2004 08/184Influenza anti A/chick/Hong Kong/G9/1997/（H9） HA serum （NIBRG-94）（H9N1） 08/202Influenza Antigen Hong Kong/1073/99 （H9N2） 08/208Influenza anti A/Cambodia/R0405050/2007 （H5） HA serum （NIBRG-86） 08/210Influenza Antigen A/Cambodia/R0405050/2007 （H5N1） NIBRG-88 08/216Tetanus Toxoid Adsorbed （4th International Standard） 08/218Influenza Antigen A/chick/Hong Kong/G9/1997 （H9N2） NIBRG-91 08/228Influenza anti A/Brisbane/10/2007- like HA serum 08/246Influenza Antigen A/mallard/England/727/2006 （H2N3） NIBRG-107 08/268Influenza Antigen A/Brisbane/10/2007-like （Prepared from A/Uruguay/716/2007 （NYMC X-175C）） 08/278Influenza Virus Infectious B/Brisbane/33/2008 08/280Influenza Virus Infectious IVR-148 08/300Influenza virus infectious NYMC X-175C 08/304Influenza Antigen B/Brisbane/60/2008-like 08/352Influenza anti A/Japan/305/57 （H2） HA serum （A/Singapore/1/57-Like） （Sheep SH398） 08/356Influenza Virus Infectious BX-31 08/360Influenza Antigen A/New York/107/2003 （H7N2） NIBRG-109 08/362Influenza Virus Infectious NIB-58 08/364Influenza anti A/mallard/England/727/2006 （N3） NA serum （NIBRG-107） （Sheep SH503） 09/100Influenza Virus Infectious NIBRG-122 09/130Influenza Antigen A/California/7/2009 （H1N1）v （NYMC-179A） （Egg derived） 09/146Clostridium Sordellii anti-serum （1st International standard） 09/154Influenza Virus Infectious B/Brisbane/60/2008 09/168Anti-Meningococcal factor H binding protein variant 1 （JAR4） monoclonal antibody 09/170Influenza Antigen A/California/7/09 （H1N1）v （NYMCX-179A） （Cell Derived） 09/174Influenza Antigen A/Vietnam/1194/2004 （H5N1） NIBRG-14 09/184Influenza Antibody （human） to A/California/7/2009 "like" （H1N1v） （1st International Standard） 09/194Influenza Antigen A/California/7/2009 （H1N1v） （NIBRG-121xp） （Egg Derived） 09/196Diphtheria Antitoxin Equine DI 09 10 iu/ml 09/204Influenza Virus Infectious A/Perth/16/2009 09/208Influenza Virus Infectious NYMC X-179A 09/216Influenza Virus Infectious IVR-153 09/236Influenza Virus Infectious NYMC X-183 09/248Influenza Virus Infectious NIBRG-121xp 09/268Influenza Virus Infectious NYMC X-185 09/274Influenza Virus Infectious A/Brisbane/59/2007 09/276Influenza Virus Infectious NIB-64 09/280Influenza Virus Infectious NYMC X-187 09/290Influenza Antigen A/California/7/09 （H1N1）v （NYMC-181） （Egg Derived） 09/294Influenza Virus Infectious IVR-155 09/304Influenza Virus Infectious NIBRG-147 09/306Influenza Antigen A/Wisconsin/15/09 （H3N2） （NYMCX-183） 09/310Influenza Virus Infectious NYMC X-181 09/314Influenza Anti B Neuraminidase Serum （B/Florida/4/2006） 09/316Influenza Virus Infectious NYMC BX-35 09/318Influenza Antigen A/Victoria/210/09 （H3N2） （NYMCX-187） 10/102Influenza Antigen B/Brisbane/60/2008 Reassortant （NYMC BX-35） 10/106Influenza Antiserum A/Brisbane/59/2007 （H1N1）（IVR-148） HA （sheep 516 and 517） 10/120Influenza Virus Infectious A/California/7/2009 10/122Diphtheria Polyclonal Antibody 10/128Diphtheria Monoclonal Antibody 10/130Tetanus Polyclonal Antibody 10/132Tetanus Monoclonal Antibody 10/134Influenza Anti-B/Brisbane/60/2008 HA serum 10/146Influenza Anti-A/Perth/16/2009 HA Serum 10/182Influenza Anti A/Hong Kong 1073/99 （N2）NA Serum （Sheep SH395 SH396） 10/214Influenza Virus Infectious NIB-74 10/216Influenza Anti A/California/7/2009 （N1） NA Serum （Sheep SH 521） 10/218Influenza Virus Infectious IVR-158 10/226Influenza Anti-A/California/7/2009 （H1N1） HA Serum 10/230Influenza virus infectious B/Brisbane/60/2008 30990 E6 10/244Clostridium Perfringens Beta Antitoxin 2CPBETAATClostridium Perfringens Epsilon Antitoxin 2CPEPSILONATGas Gangrene （Cl. Perfringens（Cl. Welchii） Type A）, Equine 59/015Botulinum Antitoxin Equine Type A 59/021Botulinum Antitoxin Equine Type B 60/001Tetanus Antitoxin, Equine, for Bioassay 60/013Botulinum Antitoxin Equine Type D 61/001Gas Gangrene Antitoxin （Cl. Histolyticum）, Equine 63/005Diphtheria Antitoxin, Equine, for Flocculation Test 63/007Gas Gangrene Antitoxin （Cl. Septicum）, Equine 64/014Gas Gangrene Antitoxin （Cl. Oedematiens）, Equine 64/024Tetanus Antitoxin, Equine, for Flocculation Test 66/021Diphtheria Antitoxin, Equine 66/153Anti-Rubella Serum, Human 67/182Diphtheria Toxoid, Plain 69/017Cholera Vaccine （Inaba） 73/554Opacity 5IRP 76/522Influenza anti A/Victoria/3/75 Serum（goat） 76/547Tetanus Antitoxin, Human, Immunoglobulin 76/589Influenza Antigen A/New Jersey/8/76 77/530Influenza anti A/New Jersey/8/76 （H1N1） Serum（sheep） 77/531Influenza anti B/Hong Kong/8/73 Serum（sheep） 77/568Influenza Antigen A/Texas/1/77 78/560Influenza anti A/Texas/1/77 Serum （sheep） 78/569Influenza anti A/Brazil/11/78 Serum （goat） 79/516Influenza Antigen A/USSR/92/77 79/552Influenza Antigen A/USSR/92/77 79/558Influenza Antigen A/Brazil/11/78 79/560Influenza Antigen B/Hong Kong/8/73 79/568Influenza Antigen A/Bangkok/1/79 80/517Influenza Antigen B/Singapore/222/79 80/519Influenza anti B/Singapore/222/79 Serum 80/523Influenza anti A/Bangkok/1/79 Serum （sheep） 80/525Anti Poliovirus serum types 1,2 and 3 82/585Influenza Antigen A/Philippines/2/82 83/537Influenza anti A/Philippine/2/82 Serum （sheep） 83/545Influenza Antigen A/Brazil/11/78 83/550Influenza Antigen A/Chile/1/83 84/538Influenza Antigen B/Norway/1/84 84/542Influenza anti B/USSR/100/83 Serum（sheep） 84/636Influenza anti A/Chile/1/8 Serum（sheep） 84/640Influenza anti A/equine/Prague/56 （H7N7） Serum（goat） 84/673Influenza anti A/equine/Miami/63 （H3N8） Serum（goat） 84/677Influenza anti A/Equine/Kentucky/1/81 HA Serum （sheep） 85/516Influenza Antigen A/Equine/Kentucky/1/81 85/520Influenza Antigen A/Equine/Prague/56 （H7N7） 85/553Influenza Antigen A/Mississippi/1/85 86/576Influenza anti A/Mississippi/1/85 Serum（sheep） 86/590Influenza anti B/Ann Arbor/1/86/HA Serum （sheep） 86/592Influenza Antigen B/Ann Arbor/1/86 86/630Influenza Antigen A/Equine/Miami/63 87/510Influenza anti A/Leningrad/360/86 Serum （sheep） 87/578Influenza Antigen A/Leningrad/360/86 87/584Influenza Antigen A/Sichuan/2/87 87/714Influenza Antigen B/Victoria/2/87 87/774Bordela pertussis （Whole cell vaccine） 3BRP 88/522Influenza Antigen B/Beijing/7/87 88/554Influenza Antigen A/England/427/88 88/654Influenza anti A/Sichuan/2/87 Serum（sheep） 88/672Influenza anti B/Beijing/1/87 Serum（sheep） 88/678Influenza anti A/England/427/88 Serum（sheep） 88/846Anti-Bordela pertussis serum （Human） 89/530Influenza Antigen A/OMS/5389/88 89/568Bordela pertussis （W28） LPS 2ug 89/594Bordela pertussis anti-agglutinogen 1（rabbit） 89/596Bordela pertussis anti-agglutinogen 2 （rabbit） 89/598Bordela pertussis anti-agglutinogen 3 （rabbit） 89/600Bordela pertussis （W28） LPS25ug 89/670Influenza Antigen A/Shanghai/16/89 90/500Influenza Antigen A/Guizhou/54/89 90/502Influenza anti A/Guangdong/39/89 Serum（sheep） 90/504Bordela Pertussis toxin （PT） 90/518Bordela pertussis, filamentous haemagglutinin （FHA） 90/520Mumps Vaccine （Live） 90/534Bordela pertussis 69kD 90/654Influenza Virus infectious NIB-26 （H3N2） 90/784Poliomyelitis Vaccine （Inactivated） 91/574Influenza anti A/Taiwan/1/86 Serum （sheep） 91/612Influenza Virus infectious A/Texas/36/91 （H1N1） 91/660Influenza Virus infectious NIB-27 （H1N1） 91/670Rubella Vaccine （Live） 91/688Influenza Antigen A/Texas/36/91 92/530Influenza anti B/Yamagata/16/88 Serum（sheep） 92/582Influenza Antigen B/Yamagata/16/88 92/628Influenza anti A/Beijing/352/89 （H3N2） Serum （sheep） 92/632Measles Vaccine （Live） 92/648Influenza Virus infectious A/Beijing/32/92 （H3N2） 92/734Influenza Virus infectious A/Shanghai/24/90 92/738Influenza Antigen A/Beijing/32/92 93/500Influenza Antigen A/Shanghai/24/90 93/516Influenza anti A/Beijing/32/92 （H3N2） Serum （sheep） 93/518Influenza anti A/Shanghai/24/90 （H3N2） Serum （sheep） 93/522Influenza Virus infectious A/Beijing/359/89 （H3N2） 93/568Influenza Virus infectious A/Guizhou/54/89 （H3N2） 93/572Influenza Virus infectious A/Shangdong/9/93 （H3N2） 93/686Influenza Virus infectious B/Panama/45/90 93/692Influenza Virus infectious A/Harbin/15/92 （H3N2） 93/816Influenza Antigen B/Panama/45/90 94/500Influenza anti A/Shanghai/9/93 Serum（sheep） 94/504Influenza Antigen A/Shangdong/9/93 94/516Influenza anti B/Panama/45/90 Serum（sheep） 94/520Pertussis Vaccine Whole Cell 94/532Influenza Virus infectious A/Johannesburg/33/94 （H3N2） 94/758Influenza Virus infectious B/Beijing/184/93 94/760Influenza Virus infectious RESVIR-8 （H3N2） 94/762Influenza Virus infectious NIB-34 （H3N2） 94/766MAPREC analysis of Poliovirus type 3 （Sabin）. Synthetic DNA 100% 472-C 94/790Hepatitis A Vaccine, inactivated 95/500Influenza Antigen A/Texas/36/91 95/510Influenza Antigen A/Johannesburg/33/94 95/516Influenza anti A/Johannesburg/33/94 Serum（sheep） 95/524Influenza anti A/Taiwan/1/86 Serum （H1N1） 95/536MAPREC analysis of Poliovirus type 3 （Sabin） Synthetic DNA 0.9% 472-C 95/542Anti-Meningococcal Serogroup A mAb 95/674Anti-Meningococcal Serogroup C mAb 95/678Anti-Meningococcal Serogroup B mAb 95/750Influenza Virus infectious A/Wuhan/359/95 （H3N2） 95/758Anti-Hib Human Reference Serum 96/536MAPREC analysis of Poliovirus type 3 （Sabin） Low virus reference 0.7%472-C 96/572MAPREC analysis of Poliovirus type 3 （Sabin） High virus reference 1.1%472-C 96/578Influenza Virus infectious A/Bayern/7/95 96/830Influenza Virus infectious RESVIR-9 （H3N2） 96/836Influenza Virus infectious A/Shenzhen/227/95 （H1N1） 96/848Influenza Virus infectious NIB-39 （H1N1） 96/850Influenza Antigen A/Johannesburg/82/96 97/518Bordela pertussis anti 69kD serum （sheep） 97/558Bordela pertussis anti FHA serum （sheep） 97/564Bordela pertussis PT anti serum （sheep） 97/572Bordela pertussis anti Fim3 serum （sheep） 97/574Influenza Antigen A/Equine/Newmarket/2/93 97/584Influenza Antigen A/Equine/Newmarket/1/93 97/596Influenza anti A/equine/Newmarket/1/93 Serum（sheep） 97/610Influenza anti A/Nanchang/933/95 （H3N2） 97/612Influenza anti A/Equine/Newmarket/2/93 （H3N8） HA Serum （SH-376） 97/614Bordela pertussis anti serum （mouse） 1RR 97/642Anti-Measles serum 97/648AntiStreptolysin O 97/662Influenza Virus infectious IVR-108 （H3N2） 97/692Influenza Virus infectious A/duck/Sing-Q/119/97 （H5N3） 97/722Influenza Virus infectious B/Harbin/7/94 97/726Influenza Antigen B/Harbin/7/94 97/748MAPREC analysis of Poliovirus type 2 （Sabin）, low virus reference 0.65%481-G 97/756MAPREC analysis of Poliovirus type 2 （Sabin） Synthetic DNA 0.67%481-G 97/758Influenza Antigen A/Beijing/262/95 97/760MAPREC analysis of Poliovirus type 2 （Sabin） Synthetic DNA, 100%481-G 98/524Influenza Virus infectious RESVIR-13 （H3N2） 98/544Diphtheria and Tetanus Antitoxin, Guinea Pig Serum 98/572MAPREC analysis of Poliovirus type 2 （Sabin）, high virus reference 1.21% 481-G 98/596Influenza Virus infectious NIB-40 （H5N3） 98/600Influenza anti B/Harbin/7/94/HA Serum （sheep） 98/604Influenza Virus infectious ARIV-1 （H5N3） 98/610Influenza anti A/Hong Kong/489/97 （H5N1） Serum （sheep） 98/666Control Guinea Pig Serum 98/686Meningococcal group A polysaccharide 98/722Influenza Virus infectious Resvir-14 （H3N2） 98/762Influenza anti A/Beijing/262/95 Serum （sheep） 98/772Influenza Antigen B/Shangdong/7/97 98/774Influenza Virus infectious A/Sichuan/346/98 （H3N2） 98/778Anti-PT S1 subunit Monoclonal Antibody （1B7） 99/506Anti-PT S1 subunit Monoclonal Antibody （1D7） 99/508Anti-PT S1 subunit Monoclonal Antibody （3F11） 99/510Anti-PT S1 subunit Monoclonal Antibody （10D6） 99/512Anti-PT S1 subunit Monoclonal Antibody （8G4） 99/514Anti-PT S1 subunit Monoclonal Antibody （E1E） 99/516Anti-PT S1 subunit Monoclonal Antibody （E2E） 99/518Anti-PT S1subunit Monoclonal Antibody （3F10） 99/520Anti-PT S1 subunit Monoclonal Antibody （11D9） 99/522Anti-PT S1 subunit Monoclonal Antibody （4D10） 99/524Anti-PT S23 subunit Monoclonal Antibody （11E6） 99/526Anti-PT S23 subunit Monoclonal Antibody （10C9） 99/528Anti-PT S23 subunit Monoclonal Antibody （10B5） 99/530Anti-PT S23 subunit Monoclonal Antibody （G9A） 99/532Anti-PT S23 subunit Monoclonal Antibody （3F6） 99/534Anti-PT S2 subunit Monoclonal Antibody （3A12） 99/536Anti-PT S2 subunit Monoclonal Antibody （2H3） 99/538Anti-PT S2 subunit Monoclonal Antibody （9G8） 99/540Anti-PT S3 subunit Monoclonal Antibody （7E10） 99/542Anti-PT S3 subunit Monoclonal Antibody （7G11） 99/544Anti-PT S3 subunit Monoclonal Antibody （4G5） 99/546Anti-PT S3 subunit Monoclonal Antibody （2E12） 99/548Anti-PT S3 subunit Monoclonal Antibody （6F8） 99/550Anti-PT S4 subunit Monoclonal Antibody （7F2） 99/554Anti-PT S4 subunit Monoclonal Antibody （6B3） 99/556Anti-PT S4 subunit Monoclonal Antibody （6G8） 99/558Anti-PT S4 subunit Monoclonal Antibody （9F3） 99/560Anti-PT S4 subunit Monoclonal Antibody （1H2） 99/562Anti-PT S4 subunit Monoclonal Antibody （9C6） 99/564Anti-PT S4 subunit Monoclonal Antibody （6D6） 99/566Anti-PT S5 subunit Monoclonal Antibody （7E3） 99/568Anti Filamentous Haemagglutinin Monoclonal Antibody （1C6） 99/570Anti-Filamentous haemagglutinin Monoclonal Antibody （2E9） 99/572Anti Filamentous Haemagglutinin Monoclonal Antibody （12G10） 99/574Influenza Antigen B/Yamanashi/166/98 99/586Methylated Human Serum Albumin （mHSA） 99/592Influenza Antigen A/Sydney/5/97 99/614Yellow Fever Vaccine 99/616Influenza Antigen A/Sydney/5/97 99/624Anti-Meningococcal human reference serum CDC1992 99/706Influenza Antigen A/Singapore/1/57 （H2N2） 99/714Influenza Virus infectious RESVIR 16 （H3N2） 99/824Influenza Antigen B/Yamanashi/166/98 99/828Botulinum Antitoxin Equine Type B BUSBClostridium novyi （alpha） Toxoid COTClostridium Welchii （Perfringens）（Beta） Toxoid CwBT CWBETATDClostridium Welchii （Perfringens）（ Epsilon） Toxoid CwDT CWEPSILONTDBordela pertussis anti FHA serum （mouse） JNIH-11Bordela pertussis PT（ LPF） anti serum, （mouse） JNIH-12Acellular Pertussis Vaccine - 1st IS JNIH-3Bordela pertussis filamentous haemagglutinin （FHA） JNIH-4Bordela pertussis toxin （PT） 1st IS JNIH-5Newcastle Disease Vaccine （Inactivated） NVIAGas Gangrene Antitoxin （Cl. novyi）, Equine OEGas Gangrene Antitoxin （Cl. Perfringens alpha antitoxin） Equine PEPurified Protein Derivative （PPD） of M Avium Tuberculin PPDAPurified Protein Derivative （PPD） of Bovine Tuberculin PPDBOVPurified Protein Derivative （PPD） of M. Tuberculosis Tuberculin PPDTAnti-rubella Immunoglobulin, Human RUBI-1-94Smallpox Vaccine SMVAnti-Staphylococcal P-V Leucocidin serum, Equine SPLSStaphylococcus Alpha Antitoxin, Equine STADiphtheria （Schick） Test Toxin STTTetanus Immunoglobulin, Human TE-3Typhoid Vaccine （acetone-inactivated） TYVKTyphoid Vaccine （heat-phenol-inactivated） TYVLGas Gangrene Antitoxin （Cl. Septicum）, Equine VIAnti-Yellow Fever Serum, monkey YF